Workflow
WILLING CORP.(002667)
icon
Search documents
威领新能源股份有限公司 关于筹划控制权变更事项继续停牌的公告
Core Viewpoint - The company is undergoing a significant change in control due to the planned transfer of shares by its controlling shareholder, Shanghai Lingyi New Materials Co., Ltd., which may lead to a change in the company's actual controller [1][2]. Group 1: Share Transfer and Control Change - The controlling shareholder, Shanghai Lingyi, and the actual controller, Mr. Huang Da, are planning to transfer a total of 20,233,784 shares, representing 7.7646% of the company's total share capital, through a negotiated agreement [1]. - The completion of the share transfer will result in the acquirer becoming the largest shareholder of the company, potentially leading to a change in control and possibly leaving the company without an actual controller [1]. Group 2: Stock Suspension - The company's stock (stock code: 002667, stock abbreviation: Weiling Shares) has been suspended from trading since November 25, 2025, to ensure fair information disclosure and protect investor interests amid the ongoing negotiations [2]. - The company has applied for an extension of the stock suspension, which will continue until at least November 27, 2025, due to the need for internal approval processes related to the transaction [2]. Group 3: Information Disclosure - During the stock suspension, the company will adhere to legal and regulatory requirements for information disclosure and will announce updates as the situation progresses [3]. - The company emphasizes the uncertainty surrounding the planned control change and urges investors to pay attention to future announcements [3].
威领新能源股份有限公司关于筹划控制权变更事项继续停牌的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002667 证券简称:威领股份 公告编号:2025-082 威领新能源股份有限公司关于筹划控制权变更事项继续停牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 (2)关于本次筹划控制权变更事项,目前仅处于筹划、意向阶段,各方还需就正式协议具体条款进行 磋商,尚需履行各自审批程序并签署正式协议。本次交易事项目前尚存在不确定性。敬请广大投资者谨 慎决策,注意投资风险。 公司近日收到控股股东上海领亿、实际控制人黄达先生通知,正在筹划所持股份转让事项,拟以协议转 让方式转让各方合计持有的20,233,784股上市公司股份(占上市公司总股本的7.7646%)。股份转让完 成后,受让方将成为上市公司第一大股东。该事项可能导致公司控制权发生变更,亦可能导致公司出现 无实际控制人情形。 鉴于该事项正在洽谈中,尚存不确定性,为保证公平信息披露,维护投资者利益,避免造成公司股价异 常波动,根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第6号一一停 复牌》 ...
筹划控制权变更,威领股份11月27日起继续停牌
Bei Jing Shang Bao· 2025-11-26 13:15
威领股份表示,目前公司控股股东上海领亿、实际控制人黄达正与对手方积极推进本次交易的相关工 作,且交易各方需履行相关内部审批程序。待上述事项确定后,公司将及时发布相关公告并申请公司股 票复牌。 北京商报讯(记者 马换换 李佳雪)11月26日晚间,威领股份(002667)披露公告称,因筹划控制权变 更事项,公司股票自11月27日开市起继续停牌。 公告显示,威领股份近日收到控股股东上海领亿新材料有限公司(以下简称"上海领亿")、实际控制人 黄达通知,正在筹划所持股份转让事项,拟以协议转让方式转让各方合计持有的约2023.38万股公司股 份(占公司总股本的7.7646%)。股份转让完成后,受让方将成为公司第一大股东。该事项可能导致公 司控制权发生变更,亦可能导致公司出现无实际控制人情形。 ...
威领股份:关于筹划控制权变更事项继续停牌的公告
Zheng Quan Ri Bao· 2025-11-26 13:11
证券日报网讯 11月26日晚间,威领股份发布公告称,因公司的控股股东上海领亿新材料有限公司(简 称"上海领亿")、实际控制人黄达先生正在筹划重大事项,该事项可能导致公司控制权发生变更。鉴于 该事项正在洽谈中,尚存不确定性,为保证公平信息披露,维护投资者利益,避免造成公司股价异常波 动,根据相关规定,经公司向深圳证券交易所申请,公司股票已于2025年11月25日(星期二)开市起停 牌。目前公司控股股东上海领亿、实际控制人黄达先生正与对手方积极推进本次交易的相关工作,且交 易各方需履行相关内部审批程序,公司预计无法在2025年11月27日(星期四)开市起复牌,根据相关规 定,经公司向深圳证券交易所申请,公司股票将于2025年11月27日(星期四)开市起继续停牌。 (文章来源:证券日报) ...
11.26犀牛财经晚报:我国医疗器械市场规模预计达1.22万亿元奥司他韦7天销量飙升237%
Xi Niu Cai Jing· 2025-11-26 10:28
Group 1: Storage Market Dynamics - The storage spot market is experiencing strong demand, leading to continued price increases for finished products, despite high prices [1] - Customers with low inventory levels are gradually accepting new pricing agreements, providing manufacturers with confidence to raise prices [1] - The significant price increases are affecting retail markets, with online and offline retailers raising prices for memory modules and SSDs, potentially reducing consumer purchasing willingness [1] Group 2: DRAM Industry Forecast - According to TrendForce, the DRAM industry revenue is expected to grow by 30.9% quarter-on-quarter in Q3 2025, reaching $41.4 billion due to rising contract prices and increased shipment volumes [1] - The fourth quarter is anticipated to see a significant increase in contract prices, with conventional DRAM prices expected to rise by 45%-50% [1] - The overall contract prices for conventional DRAM and HBM combined are projected to increase by 50%-55% [1] Group 3: Medical Device Market Growth - The Chinese medical device market is projected to reach ¥1.22 trillion by 2025, with over 33,000 production enterprises expected by the end of 2024, marking a 27.8% increase from the end of the 13th Five-Year Plan [2] - The industry is transitioning from "catching up" to "running alongside and leading," supporting the "Healthy China" strategy [2] Group 4: Flu Season Impact on Pharmaceuticals - The flu season has started early in China, with a 237% increase in sales of Oseltamivir over the past week, and a 180% increase for Maviral [2] - The peak of the flu season is expected between mid-December and early January [2] Group 5: Cinema Industry Growth - As of October 2023, China has added 233 cinemas and 1,588 screens, totaling 15,438 operating cinemas and 92,556 screens nationwide [3] - County-level cinemas account for 21.06% of the total, while town cinemas make up 18.01% [3] Group 6: Innovations in Medical Technology - Novo Nordisk's Kyinsu, the world's first weekly insulin and GLP-1 receptor agonist combination, has been approved in the EU for adults with type 2 diabetes [3] - This innovation represents a significant advancement in diabetes treatment options [3] Group 7: Corporate Developments - Allianz Partners plans to lay off 1,500 to 1,800 employees over the next 12-18 months, primarily in call center roles due to automation [5] - Novartis announced plans to cut up to 550 jobs in Switzerland by the end of 2027 as part of production adjustments [5]
11月26日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-26 10:21
Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]
威领股份:控股股东筹划重大事项 股票继续停牌
人民财讯11月26日电,威领股份(002667)11月26日公告,控股股东上海领亿、实控人黄达正在筹划重 大事项,该事项可能导致公司控制权发生变更。目前公司控股股东上海领亿、实际控制人黄达正与对手 方积极推进本次交易的相关工作,且交易各方需履行相关内部审批程序,公司预计无法在2025年11月27 日开市起复牌,根据相关规定,公司股票将于2025年11月27日开市起继续停牌。 ...
威领股份:筹划控制权变更事项 继续停牌
Zhi Tong Cai Jing· 2025-11-26 09:17
目前公司控股股东上海领亿、实际控制人黄达先生正与对手方积极推进本次交易的相关工作,且交易各 方需履行相关内部审批程序,公司预计无法在2025年11月27日(星期四)开市起复牌,根据相关规定,经 公司向深圳证券交易所申请,公司股票将于2025年11月27日(星期四)开市起继续停牌。 威领股份(002667)(002667.SZ)发布公告,公司的控股股东上海领亿新材料有限公司(简称"上海领 亿")、实际控制人黄达先生正在筹划重大事项,该事项可能导致公司控制权发生变更。公司股票已于 2025年11月25日开市起停牌。 ...
威领股份(002667) - 关于筹划控制权变更事项继续停牌的公告
2025-11-26 09:15
| 证券代码 | 证券简称 | 停复牌 | | 停牌 | 停牌期间 | | 停牌 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 类型 | | 起始日 | | | 终止日 | | | 002667 | 威领股份 | A 股 | 停牌 | 2025/11/27 | 2025/11/27 | 至 | 2025/12/1 | 2025/12/2 | | | | | | | 2025/12/1 | | | | (2)关于本次筹划控制权变更事项,目前仅处于筹划、意向阶段,各方还 需就正式协议具体条款进行磋商,尚需履行各自审批程序并签署正式协议。本次 交易事项目前尚存在不确定性。敬请广大投资者谨慎决策,注意投资风险。 公司近日收到控股股东上海领亿、实际控制人黄达先生通知,正在筹划所持 股份转让事项,拟以协议转让方式转让各方合计持有的 20,233,784 股上市公司 股份(占上市公司总股本的 7.7646%)。股份转让完成后,受让方将成为上市公 司第一大股东。该事项可能导致公司控制权发生变更,亦可能导致公司出现无实 际控制人情形。 ...
紧急停牌!黄达“败退”威领股份 股价提前涨停
Bei Jing Shang Bao· 2025-11-25 11:11
Core Viewpoint - The controlling shareholder of Weiling Co., Ltd. (002667), Huang Da, has decided to relinquish control of the company after five years, leading to a potential change in control and a significant drop in the company's performance in recent years [2][6]. Group 1: Shareholder Changes - Weiling Co., Ltd. announced on November 24 that its controlling shareholder, Shanghai Lingyi New Materials Co., Ltd., and Huang Da are planning a major matter that may lead to a change in control, resulting in a stock suspension starting November 25 [2][4]. - The company plans to transfer a total of 2,023,380 shares, representing 7.7646% of the total share capital, which will make the acquirer the largest shareholder [4]. - The stock price of Weiling Co., Ltd. hit the daily limit on the same day the suspension was announced, closing at 16.9 yuan per share, with a total market value of 4.404 billion yuan [4]. Group 2: Financial Performance - Weiling Co., Ltd. has faced significant financial challenges, with a revenue decline of over 50% year-on-year in the first three quarters of this year, resulting in continued net losses [2][8]. - Financial data shows that from 2022 to 2024, the company reported net profits of approximately 82.03 million yuan, -222.3 million yuan, and -308 million yuan, respectively, indicating a trend of increasing losses [8]. - The decline in revenue is attributed to a decrease in income from lithium compounds and derivatives during the reporting period [9]. Group 3: Business Transition - Weiling Co., Ltd. has shifted its main business focus from heavy machinery manufacturing to lithium resource operations, changing its name from "Anzhong Co., Ltd." to "Weiling Co., Ltd." in June 2023 [7].